The camptothecins Article Report uri icon


MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Camptothecin
  • Colorectal Neoplasms


  • Supported by detailed understanding of their mechanism of action, and facilitated by chemical manipulations that have amplified their solubility, the camptothecins have advanced to the forefront of several areas of therapeutic and developmental chemotherapy. Additive and synergistic laboratory interactions with other cytotoxic drugs have been exploited to allow development of camptothecin-based multidrug regimens, which are showing important activity in several malignancies. Topotecan and irinotecan are already in widespread use in clinical practice, and newer agents with promising preclinical activity are in various stages of clinical assessment. As knowledge of molecular and biochemical mechanisms of action and resistance continues to expand, newer and better camptothecin-based strategies for treatment of malignant disease are likely to evolve.

publication date

  • June 28, 2003



  • Report


Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(03)13780-4

PubMed ID

  • 12842380

Additional Document Info

start page

  • 2235

end page

  • 42


  • 361


  • 9376